Literature DB >> 1698814

Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells.

S Dhib-Jalbut1, C V Kufta, M Flerlage, N Shimojo, H F McFarland.   

Abstract

T-lymphocyte recognition of antigen either on antigen-presenting cells (APC) necessary for the generation of an immune response or on target cells during the effector phase of a cellular immune response requires expression of HLA molecules. Although immune mechanisms operate in many disease processes of the central nervous system (CNS), cells of the CNS generally express low levels of HLA molecules. In this study, the potential for upregulation of HLA molecules on adult human glial cells was examined. Moreover, the functional implication of this upregulation was assessed by the capacity of glial cells to process and present target antigens to HLA class I-restricted influenza-specific and class II-restricted myelin basic protein (MBP)-specific CTL lines. Glial cells cultured from adult human surgical brain specimens or cells from established glioblastoma multiforme cell lines were studied. Lysis by antigen-specific CTLs was dependent on treatment of the target cell with interferon-gamma. The lysis was HLA restricted and antigen specific. The results indicate that adult human glial cells can process and present antigen to HLA-restricted CTLs but require the upregulation of HLA molecules. These findings have implications for infectious and autoimmune diseases of the CNS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698814      PMCID: PMC7119691          DOI: 10.1016/0165-5728(90)90163-h

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  26 in total

1.  Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes.

Authors:  D Sun; H Wekerle
Journal:  Nature       Date:  1986 Mar 6-12       Impact factor: 49.962

2.  Site-directed mutagenesis of an HLA-A3 gene identifies amino acid 152 as crucial for major-histocompatibility-complex-restricted and alloreactive cytotoxic-T-lymphocyte recognition.

Authors:  E P Cowan; M L Jelachich; J E Coligan; W E Biddison
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

4.  Astrocytes present myelin basic protein to encephalitogenic T-cell lines.

Authors:  A Fontana; W Fierz; H Wekerle
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

5.  Distribution and quantitation of HLA-ABC and DR (Ia) antigens on human kidney and other tissues.

Authors:  K A Williams; D N Hart; J W Fabre; P J Morris
Journal:  Transplantation       Date:  1980-04       Impact factor: 4.939

6.  Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies.

Authors:  C J Wikstrand; F C Grahmann; R D McComb; D D Bigner
Journal:  J Neuropathol Exp Neurol       Date:  1985-05       Impact factor: 3.685

7.  Induction of human leukocyte antigen-A,B,C and -DR on cultured human oligodendrocytes and astrocytes by human gamma-interferon.

Authors:  M Hirayama; T Yokochi; K Shimokata; M Iida; N Fujiki
Journal:  Neurosci Lett       Date:  1986-12-23       Impact factor: 3.046

8.  Inducible expression of H-2 and Ia antigens on brain cells.

Authors:  G H Wong; P F Bartlett; I Clark-Lewis; F Battye; J W Schrader
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

9.  Immunological reactions induced by intracerebral transplantation: evidence that host microglia but not astroglia are the antigen-presenting cells.

Authors:  M Poltorak; W J Freed
Journal:  Exp Neurol       Date:  1989-03       Impact factor: 5.330

10.  Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.

Authors:  T D Geppert; P E Lipsky
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

View more
  4 in total

Review 1.  All in the head: obstacles for immune rejection of brain tumours.

Authors:  Paul R Walker; Thomas Calzascia; Pierre-Yves Dietrich
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

Review 2.  Interferons in multiple sclerosis. A review of the evidence.

Authors:  H S Panitch
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

3.  Mechanism of measles virus failure to activate NF-kappaB in neuronal cells.

Authors:  Y Y Fang; Z M Song; S Dhib-Jalbut
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

4.  Interleukin-1 beta decreases HLA class II expression on a glioblastoma multiforme cell line.

Authors:  E P Cowan; M L Pierce; S Dhib-Jalbut
Journal:  J Neuroimmunol       Date:  1991-07       Impact factor: 3.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.